Publications

Filters

Publications Atlas Journal Article Research Report

Clinical and Practice Brain diseases Cancer and cancer screening Cardiovascular disease Chronic diseases and multimorbidity Diet and nutrition Endocrinology Environmental health Eye, ear, nose and throat disorders Gastroenterology Hematology Infectious diseases Injuries and accidents Internal medicine Kidney disease Lung health Musculoskeletal diseases and disorders Organ transplantation and donation Pharmacoepidemiology and drug safety Reproductive medicine Skin diseases and disorders

Healthcare Providers and Services Acute and emergency services End-of-life care Home and community care Long-term care and continuing care Maternity and neonatal care Mental health and addictions Nursing Pediatrics Pharmacy Primary care Public health Rehabilitation Surgery

People and Society Children and young people Health and healthcare inequality Indigenous Peoples Marginalized populations Older people Racialized communities Women or gender-based research

Research and Methods Data science Decision science Epidemiology Health economics Health services research Implementation science and knowledge translation Policy and program evaluation Statistics Trials

From

ICES Central ICES McMaster ICES North ICES Queen's ICES UofT ICES uOttawa ICES Western

Cancer Cardiovascular Chronic Disease & Pharmacotherapy Kidney, Dialysis & Transplantation Life Stage Mental Health & Addictions Populations & Public Health Primary Care & Health Systems

Showing 1-10 of 75

Journal Article

14/04/2022

Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: a population-based time series analysis

Garg R, Kitchen SA, Men S, Campbell TJ, Bozinoff N, Tadrous M, Antoniou T, Wyman J, Werb D, Munro C, Gomes T. Drug Alcohol Depend. 2022; 236:109459. Epub 2022 Apr 14.

Journal Article

11/03/2022

The risk of ventricular dysrhythmia or sudden death in patients receiving serotonin reuptake inhibitors with methadone: a population-based study

Antoniou T, McCormack D, Tadrous M, Juurlink DN, Gomes T. Front Pharmacol. 2022; 13:861953. Epub 2022 Mar 11.

Journal Article

08/03/2022

Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study

Gomes T, McCormack D, Bozinoff N, Tadrous M, Antoniou T, Munro C, Campbell T, Paterson JM, Mamdani M, Sproule B. Addiction. 2022; 117(7):1972-81. Epub 2022 Mar 8.

Journal Article

01/03/2022

Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: a population-based time-series analysis

Kitchen SA, Campbell TJ, Men S, Bozinoff N, Tadrous M, Antoniou T, Wyman J, Werb D, Munro C, Gomes T. Int J Drug Policy. 2022; 103:103644. Epub 2022 Mar 1.

Journal Article

01/03/2022

Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation

Gomes T, Campbell TJ, Kitchen SA, Garg R, Bozinoff N, Men S, Tadrous M, Munro C, Antoniou T, Werb D, Wyman J. JAMA. 2022; 327(9):846-55. Epub 2022 Mar 1.

Journal Article

03/02/2022

Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada

Young S, Koll G, McCormack D, Campbell T, Leece P, Strike C, Srivastava A, Antoniou T, Bayoumi AM, Gomes T. Int J Drug Policy. 2022; 102:103601. Epub 2022 Feb 3.

Journal Article

14/12/2021

The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis

Boone CG, Antoniou T, Juurlink DN, von den Baumen TR, Kitchen SA, Richards GC, Tadrous M, Gomes T. CMAJ Open. 2021; 9(4):E1181-6. Epub 2021 Dec 14.

Journal Article

06/05/2021

Healthcare utilization in medically complex people living with HIV before and after admission to an HIV-specific community facility: a pre-post comparison study

Stewart A, Antoniou T, Graves E, Plumptre L, Carusone SC. CMAJ Open. 2021; 9(2):E460-5. Epub 2021 May 6.

Journal Article

11/02/2021

Herpes zoster in older adults in Ontario, 2002-2016: investigating incidence and exploring equity

Buchan SA, Daneman N, Wang J, Wilson SE, Garber G, Wormsbecker AE, Antoniou T, Deeks SL. PLoS One. 2021; 16(2):e0246086. Epub 2021 Feb 11.

Journal Article

18/11/2020

Impact of policy changes on the provision of naloxone by pharmacies in Ontario Canada: a population-based time series analysis

Antoniou T, Martins D, Campbell T, Tadrous M, Munro C, Leece P, Mamdani M, Juurlink DN, Gomes T. Addiction. 2021; 116(6):1514-20. Epub 2020 Nov 18.

« Previous 1 2 3 4 5 … 8 Next »

Publications

Filters

Resource Type

Topic

Date

ICES Scientists

ICES Site

Research Program

Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: a population-based time series analysis

The risk of ventricular dysrhythmia or sudden death in patients receiving serotonin reuptake inhibitors with methadone: a population-based study

Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study

Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: a population-based time-series analysis

Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation

Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada

The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis

Healthcare utilization in medically complex people living with HIV before and after admission to an HIV-specific community facility: a pre-post comparison study

Herpes zoster in older adults in Ontario, 2002-2016: investigating incidence and exploring equity

Impact of policy changes on the provision of naloxone by pharmacies in Ontario Canada: a population-based time series analysis